logo
The case for super cool materials to make Indian cities cope with the new climate normal of urban heat

The case for super cool materials to make Indian cities cope with the new climate normal of urban heat

Time of India24-04-2025

Ansar Khan is an urban climatologist and an Assistant Professor at the Department of Geography at Lalbaba College, Calcutta University. He has several peer-reviewed publications in various academic journals. LESS ... MORE
Cities worldwide are experiencing a shift in their urban climate, with extreme heat becoming a defining challenge due to rapid urbanization and climate change. Indian cities, in particular, are facing unprecedented temperature surges, escalating public health crises, economic pressures, and infrastructure failures. Scientists warn that without urgent deployment of advanced heat mitigation strategies, urban centres will become increasingly unlivable, with dire consequences for human health, energy systems, and economic stability.
Rising urban temperatures have already led to record-breaking heat waves, with severe health impacts. Hospitals are reporting a surge in cases of heat exhaustion, dehydration, cardiovascular distress, and respiratory complications, disproportionately affecting vulnerable populations such as the elderly, children, and outdoor workers. Studies show that prolonged exposure to extreme heat heightens the risk of heat stroke, kidney failure, and mental health disorders, while also exacerbating chronic conditions like diabetes and hypertension. The urban heat island effect further intensifies the crisis by trapping heat, keeping night-time temperatures dangerously high, and reducing the body's ability to recover from prolonged exposure.
Beyond health concerns, extreme heat is placing immense pressure on energy infrastructure, with electricity demand for cooling skyrocketing. In cities like Kolkata, air conditioning use has surged by 40% during peak summer months, leading to frequent power failures. Many low-income households, unable to afford cooling solutions, remain at heightened risk of heat-induced illnesses and fatalities. Businesses, too, are suffering from increased cooling costs, reduced productivity, and economic losses as outdoor labourers face declining work hours due to unsafe working conditions.
While conventional cooling solutions such as tree plantations and green roofs are often considered, they face limitations in dense urban environments due to space constraints. Additionally, increased vegetation can sometimes raise humidity levels, promote volatile organic compound emissions, and contribute to ozone formation, worsening air quality. Recognizing these challenges, scientists are advocating for large-scale deployment of advanced heat mitigation technologies, particularly super cool materials, which have shown remarkable potential in reducing urban heat at scale.
Our research have demonstrated the effectiveness of these solutions in large-scale studies. The study in Riyadh, Saudi Arabia, assessed the impact of radiative coolers, reflective coatings, and hybrid green infrastructure across 3,323 urban buildings. The results were striking, with a peak temperature reduction of 4.5°C, a 26% decrease in annual cooling degree hours, and a 16% reduction in cooling energy consumption. When combined with energy-efficient adaptations, the total cooling demand fell by 35%, highlighting the potential of these technologies in mitigating urban overheating.
In Kolkata, where summer temperatures frequently exceed 40°C, super cool materials applied to roofs, walls, and pavements have been found to reduce peak air temperatures by 5.3°C, with sub-ambient cooling of up to 8.2°C during the hottest hours of the day. These materials utilize advanced radiative cooling and high-reflectivity coatings to dissipate heat into the atmosphere passively, significantly lowering temperatures without additional energy consumption. Unlike traditional cooling methods, super cool materials require minimal maintenance and can be scaled across dense urban landscapes, making them a viable solution for heat-prone cities.
Despite the severity of the crisis, public awareness remains low, and policymakers have yet to implement effective urban heat warning systems to protect vulnerable communities. Scientists emphasize that immediate government intervention is essential, with mandatory heat action plans, early warning alerts, and financial support for heat-resilient infrastructure.
Extreme urban heat is not a distant threat but a present emergency. Indian cities must act now to deploy large-scale cooling technologies and establish robust heat warning systems. Delaying action will lead to irreversible damage with severe consequences for human lives, economic stability, and environmental sustainability.
With climate change amplifying the urban heat island effect, the cost of inaction is rising rapidly. Scientists, urban planners, and health experts urge city authorities to prioritize climate-resilient urban design, energy-efficient cooling systems, and public education to protect millions from the growing dangers of extreme heat. Without immediate intervention, Indian cities, alongside other heat-prone regions worldwide, face the risk of becoming uninhabitable, threatening public health, economic viability, and overall quality of life.
Facebook Twitter Linkedin Email Disclaimer
Views expressed above are the author's own.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dr Reddy's, Alvotech to co-develop Keytruda biosimilar
Dr Reddy's, Alvotech to co-develop Keytruda biosimilar

Time of India

time2 hours ago

  • Time of India

Dr Reddy's, Alvotech to co-develop Keytruda biosimilar

Dr. Reddy's Laboratories and Alvotech are collaborating to develop, manufacture, and commercialize a biosimilar version of Keytruda, a highly successful cancer drug. This partnership aims to provide more affordable treatment options globally as Merck's patents begin to expire around 2028. The collaboration will enhance Dr. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Mumbai: Dr Reddy's Laboratories has entered into a collaboration with Reykjavik, Ireland-based biotech company Alvotech to co-develop, manufacture and commercialise a biosimilar version of blockbuster cancer drug Keytruda for the global (generic name is pembrolizumab ), manufactured and marketed by Merck & Co , is the most successful medicine, recording worldwide sales of $29.5 billion in 2024. It is used to treat multiple forms of the terms of the agreement, both companies will be jointly responsible for developing and manufacturing the biosimilar candidate and sharing costs and responsibilities, Hyderabad-based DRL said in a statement on to certain exceptions, each party will have the right to commercialise the product traditional generics, which often face automatic patent infringement claims, biosimilars are developed more like original drugs, complete with clinical trials and patent disclosures, giving them a better chance of overcoming legal challenges. Also, Merck's core patents on pembrolizumab in the US are expected to start expiring around 2028.'This (collaboration) demonstrates our ability to develop and manufacture high quality and affordable treatment options for patients worldwide,' Erez Israeli, chief executive of DRL, said.Róbert Wessman, chairman and CEO of Alvotech, said, 'The agreement enables us to increase the availability of cost-effective, critical biologic medications to patients worldwide.'Keytruda is approved in the US to treat 40 cancers, unlike most medicines that treat a few indications or medical India, it is approved for use in 17 indications across 10 cancers or tumour types. Oncologists mostly prescribe it to treat certain types of lung cancers, followed by gastrointestinal cancer, triple-negative breast cancer and head and neck helps the body's immune system, which is the T-cells, to detect and fight cancer cells that hide and spread in organs.'Oncology has been a top focus therapy area for us, and this collaboration will enhance our capabilities in oncology, as pembrolizumab currently represents one of the most critical therapies in immuno-oncology ,' Israeli has been out of reach for most patients in India due to its exorbitant cost – roughly about Rs 2 lakhs for each dose. However, with Merck's patent set to expire in a few years and with Indian drug manufacturers looking to come up with more affordable versions of the drug it may play a crucial role in widening adoption across a larger cohort of patients.

India's Rs 548 crore Space Leap: Shukla rides the Falcon 9 to the ISS
India's Rs 548 crore Space Leap: Shukla rides the Falcon 9 to the ISS

India.com

time3 hours ago

  • India.com

India's Rs 548 crore Space Leap: Shukla rides the Falcon 9 to the ISS

On June 10, 2025, at 5:52 PM IST (8:22 AM EDT), Group Captain Shubhanshu Shukla will lift off to the International Space Station (ISS), becoming the first Indian astronaut since 1984 to undertake such a journey. As the pilot of Axiom Mission 4 (Ax-4), he will fly aboard a SpaceX Crew Dragon spacecraft, launched on a Falcon 9 rocket from NASA's Kennedy Space Center in Florida. After approximately 28 hours of travel, the crew is expected to dock with the ISS by 10:00 PM IST on June 11, 2025. Shukla joins an elite international crew: Commander Peggy Whitson (USA, Axiom Space), and Mission Specialists Sławosz Uznański-Wiśniewski (Poland, ESA) and Tibor Kapu (Hungary, Hunor Programme). The team will spend up to 14 days aboard the ISS, conducting over 60 scientific experiments from 31 countries, including seven from India, such as research on plant growth in microgravity, muscle regeneration, and tardigrade resilience. Born on October 10, 1985, in Lucknow, Shukla is a decorated Indian Air Force test pilot with over 2,000 flight hours. He has undergone rigorous astronaut training in Russia and at SpaceX facilities in the US, and will assist in spacecraft navigation, docking, and emergency procedures during the mission. But beyond his technical role, Shukla carries India's cultural pride into space—bringing along items designed by National Institute of Design (NID) students, performing yoga in microgravity, sharing Indian delicacies like mango nectar and moong dal halwa, and planning live interactions with Indian school children and possibly Prime Minister Narendra Modi. SpaceX has revolutionized space travel economics. While NASA pays around $55 million per seat under its commercial crew program, private clients like Axiom Space are charged $52–55 million per seat, excluding stay-related fees. NASA charges $35,000 per night per astronaut for use of the ISS. India's investment for Shukla's mission seat is around ₹548 crore (approximately $65 million), while the total private mission cost per astronaut can go up to $100 million, including training and logistics. In comparison, Russia's Soyuz costs around $80–86 million per seat, Boeing's Starliner costs about $90 million, and the now-retired Space Shuttle had a cost of approximately $170 million per astronaut. For reference, cargo missions on SpaceX's Dragon cost anywhere between $21,000 and $89,000 per kg, while human missions are far costlier due to added life support and safety systems. Shukla's mission is more than just a spaceflight—it's a symbol of India's return to human space exploration. He carries a special swan named 'Joy', representing wisdom (India), resilience (Poland), and grace (Hungary). The scientific experiments onboard are expected to contribute to India's ambition of establishing a space station by 2035 and support its moon mission goals set for 2047. This mission also strengthens international space ties, especially between India and the US, following commitments made during PM Modi's 2023 visit. In every sense, Group Captain Shubhanshu Shukla's journey aboard the human-rated Falcon 9 rocket is a giant leap for India—both in science and symbolism. With his successful flight, India not only rekindles its human spaceflight legacy after four decades but also sets the stage for greater roles in global space partnerships, cutting-edge research, and inspiration for the next generation of Indian scientists, engineers, and dreamers. —E.O.M (Girish Linganna is an award-winning science communicator and a Defence, Aerospace & Geopolitical is the Managing Director of ADD Engineering Components India Pvt. Ltd., a subsidiary of ADD Engineering GmbH, Germany )

Low Effort, High Flavor: Paneer Salad Bowls For Every Day
Low Effort, High Flavor: Paneer Salad Bowls For Every Day

India.com

time3 hours ago

  • India.com

Low Effort, High Flavor: Paneer Salad Bowls For Every Day

Anaika Sohal Jun 05, 2025 This healthy bowl is made with grilled tandoori paneer cubes with cucumber, onions, cherry tomatoes, and mint-yogurt dressing. An Indian twist to the bowl by adding sauteed paneer in Indian spices over shredded lettuce, corn, bell peppers, and lemon juice. A quick and healthy breakfast recipe made from crumbled paneer tossed with cooked quinoa, parsley, olives, and a light olive oil-lime vinaigrette. A different unique variety of paneer bowl tempered with mustard seeds and curry leaves, served with grated carrot, coconut, and soaked moong dal. Tasty and healthy version of paneer bowl with soft paneer cubes with avocado slices, microgreens, roasted sunflower seeds, and tahini dressing. A tropical bowl made with cubed paneer, cherry tomatoes, cucumber, lettuce, and a drizzle of lemon-garlic hummus. For this recipe add baked or air-fried chilli paneer with sautéed broccoli, red cabbage, and a sesame-soy glaze. Read Next Story

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store